Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryotherapy and oral antihistamine for alopecia areata
IRCT20210404050843N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- May 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of betamethasone and desloratadine in alopecia areata (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Percentage of terminal hair regrowth and Patient satisfaction. Started May 2021; status: completed.
02
Drugs
betamethasonedesloratadine
03
Conditions
alopecia areata
Beyond the preview
Go deeper on IRCT20210404050843N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210404050843N1.